PSI Announces New Leadership in Latin America

PSI Announces New Leadership in Latin America

ZUG, Switzerland, May 22, 2012 (BUSINESS WIRE) -- PSI CRO, a full service Contract Research Organization, known for predictable, on-time enrollment and project delivery, announced today that Oscar Podesta has joined PSI as Head of Latin America. He holds a University degree in Biochemistry with sixteen years experience in research, a Fellowship in Clinical Microbiology and further specialization in Virology.

Prior to joining PSI, Mr. Podesta worked in the clinical research business field, working as a manager for central laboratory services and has held positions in Operations and Strategic Development at international CROs and SMOs in Latin America that have included clinical start up activities in the region.

"We are very pleased to have Oscar join PSI at a time when we are expanding our operational presence in the region which is directly driven by a strong interest and demand from our clients worldwide," said Boris Iossel, Head of Project Management, The Americas. "Oscar brings a wealth of experience and a clear understanding of specifics of growing a successful operation and understands the challenges of conducting high quality clinical studies in Latin America. Supported by our existing experienced clinical and regulatory team at our regional headquarters in Buenos Aires, Oscar will lead our expansion, oversee opening more of our new offices and manage the continuing growth of our personnel across Latin American region."

Mr. Podesta has an active role in the clinical research market in Latin America, with participation in the Chamber of CROs (Brazil and Argentina) and Committee member of the Drug Information Association Latin American event. Lastly, Mr. Podesta is currently responsible for Fundraising and Marketing for a non-profit organization focused on Ethics and Quality in Clinical Research in Latin America (FECICLA).

Mr. Podesta stated, "I am very excited with this opportunity. PSI has the strengths and resources to expand their business in the region and I am honored the company has considered me to lead this process. There is no doubt Latin America is a fertile ground for a patient recruitment centric international CRO like PSI."

About PSI CRO AG: PSI is a privately-held, full-service CRO, operating globally with 1,200 employees worldwide. Global headquarters are located in Zug, Switzerland at 113a Baarerstrasse 6300.


Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.